日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Concurrent Chemoradiotherapy with Daily Low-Dose Carboplatin in Older Patients with Unresectable Locally Advanced Non-Small-Cell Lung Cancer: Clinical Outcomes and Prognostic Significance of Systemic Inflammation Markers

老年不可切除局部晚期非小细胞肺癌患者接受每日低剂量卡铂同步放化疗:临床结果及全身炎症标志物的预后意义

Miura, Yu; Imai, Hisao; Endo, Satoshi; Hashimoto, Kosuke; Yamaguchi, Ou; Mouri, Atsuto; Masubuchi, Ken; Masubuchi, Takeshi; Fujita, Yuka; Kato, Shingo; Kagamu, Hiroshi; Kaira, Kyoichi

Prognostic value as metabolic tumor activity on (18)F-FDG uptake in thymic epithelial tumors

胸腺上皮肿瘤中(18)F-FDG摄取的代谢肿瘤活性及其预后价值

Hashimoto, Kosuke; Kaira, Kyoichi; Imai, Hisao; Mouri, Atsuto; Yamaguchi, Ou; Taguchi, Ryo; Umesaki, Tetsuya; Ichiki, Yoshinobu; Hishida, Tomoyuki; Nitanda, Hiroyuki; Kuji, Ichiei; Kagamu, Hiroshi

Synchronous occurrence of interstitial lung disease and ICANS after tarlatamab initiation in recurrent small-cell lung cancer

复发性小细胞肺癌患者在接受 tarlatamab 治疗后,间质性肺病和 ICAN 综合征同时发生

Takahara, Masakazu; Mouri, Atsuto; Yamaguchi, Ou; Uno, Tatsuhiko; Hashimoto, Kosuke; Imai, Hisao; Kagamu, Hiroshi; Kaira, Kyoichi

A Randomized Trial of Nutrition and Exercise Treatment in Patients With Pancreatic and Non-Small Cell Lung Cancer (NEXTAC-TWO)

一项针对胰腺癌和非小细胞肺癌患者的营养和运动治疗随机试验(NEXTAC-TWO)

Mitsunaga, Shuichi; Naito, Tateaki; Imai, Hisao; Kimura, Madoka; Miura, Satoru; Tanaka, Hisashi; Mizukami, Takuro; Imoto, Akira; Kondoh, Chihiro; Okuyama, Hiroyuki; Ueno, Makoto; Shiotsu, Shinsuke; Inano, Toshimi; Chitose, Haruka; Tatematsu, Noriatsu; Okayama, Taro; Mouri, Takako; Sugiyama, Miwa; Omae, Katsuhiro; Kawabata, Takanori; Mori, Keita; Takayama, Koichi

Th7R predicts chemo-immunotherapy response and survival in small cell lung cancer

Th7R 可预测小细胞肺癌的化疗-免疫治疗反应和生存期

Takei, Shota; Shiono, Ayako; Yamasaki, Satoshi; Yamaguchi, Ou; Mouri, Atsuto; Miura, Yu; Hashimoto, Kosuke; Imai, Hisao; Kaira, Kyoichi; Kagamu, Hiroshi

Correlation between T cell immunity and the duration of EGFR-TKI resistance acquisition in patients harboring EGFR mutations

T细胞免疫与携带EGFR突变患者EGFR-TKI耐药持续时间的相关性

Mouri, Atsuto; Kaira, Kyoichi; Yamaguchi, Ou; Shiono, Ayako; Miura, Yu; Hashimoto, Kosuke; Yamasaki, Satoshi; Nishihara, Fuyumi; Imai, Hisao; Kobayashi, Kunihiko; Kagamu, Hiroshi

Prognostic relevance of TROP2 expression in patients with non-small cell lung cancer receiving immunotherapy.

TROP2 表达在接受免疫治疗的非小细胞肺癌患者中的预后意义。

Hashimoto Naohito, Takei Shota, Kaira Kyoichi, Imai Hisao, Hashimoto Kosuke, Miura Yu, Shiono Ayako, Yamaguchi Ou, Mouri Atsuto, Kobayashi Kunihiko, Hamda Mei, Kagamu Hiroshi

Metabolic tumor volume on (18)F-FDG uptake as a negative predictor after ipilimumab plus nivolumab in advanced non-small cell lung cancer

代谢性肿瘤体积对(18)F-FDG摄取的影响可作为晚期非小细胞肺癌患者接受伊匹木单抗联合纳武利尤单抗治疗后的阴性预测因子

Hashimoto, Kosuke; Kaira, Kyoichi; Mouri, Atsuto; Shiono, Ayako; Miura, Yu; Yamaguchi, Ou; Imai, Hisao; Kagamu, Hiroshi; Kuji, Ichiei

Prognostic factors of liver metastases in extensive-stage small cell lung cancer receiving chemo-immunotherapy

接受化疗-免疫治疗的广泛期小细胞肺癌肝转移的预后因素

Kaira, Kyoichi; Kurata, Yuhei; Imai, Hisao; Shiono, Ayako; Miura, Yu; Hashimoto, Kosuke; Yamaguchi, Ou; Mouri, Atusto; Kagamu, Hiroshi

Prognostic biomarkers for extensive-stage small cell lung cancer receiving amrubicin following failure of chemoimmunotherapy: a retrospective cohort study

接受安柔比星治疗的广泛期小细胞肺癌患者在化疗免疫治疗失败后的预后生物标志物:一项回顾性队列研究

Kaira, Kyoichi; Imai, Hisao; Hashimoto, Kosuke; Shiono, Ayako; Yamaguchi, Ou; Miura, Yu; Mouri, Atsuto; Kagamu, Hiroshi